Current Eye Research
Current Eye Research is a peer-reviewed medical journal that publishes original research articles, review articles, and clinical studies related to the field of ophthalmology. The journal focuses on the latest advancements in the understanding of eye diseases and vision disorders, as well as the development of new treatment methods and surgical techniques.
History[edit]
Current Eye Research was first published in 1980 by Informa Healthcare, a leading provider of specialist information to the global academic and scientific communities. The journal has since become a respected source of information for eye care professionals, researchers, and academics worldwide.
Scope[edit]
The scope of Current Eye Research includes all areas of ophthalmology, with a particular emphasis on ocular physiology, ocular pharmacology, ocular pathology, and clinical ophthalmology. The journal also covers interdisciplinary topics such as neuro-ophthalmology, ocular immunology, and genetic research related to eye diseases.
Impact Factor[edit]
The Impact Factor of Current Eye Research is a measure of the frequency with which the average article in the journal has been cited in a particular year. As of 2019, the journal's Impact Factor is 2.015, indicating its significant influence in the field of ophthalmology.
See Also[edit]
- Ophthalmology
- Eye Diseases
- Vision Disorders
- Ocular Physiology
- Ocular Pharmacology
- Ocular Pathology
- Clinical Ophthalmology
- Neuro-Ophthalmology
- Ocular Immunology
- Genetic Research
References[edit]
 | This medical article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
